Actavis Plc (ACT) Tops Q3 EPS by 9c

Actavis Plc (NYSE: ACT) reported Q3 EPS of $3.19, $0.09 better than the analyst estimate of $3.10. Revenue for the quarter came in at $3.68 billion versus the consensus estimate of $3.63 billion.

Raises H214 adjusted EPS outlook to $6.60 - $6.70.

For earnings history and earnings-related data on Actavis Plc (ACT) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
• Kodiak Sciences Inc. (KOD) Misses Q2 EPS by 7c